CDKN2A and central nervous system cancer: Nanopore sequencing has occasionally been used to study gliomas, one example being the detection of mutations of the gene for the “cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) in IDH-mutated gliomas [144].